EN
HI
Lyka Labs Chart
Lyka Labs Share Key Metrics
Volume
9884.00
Market Cap
206.75 CR
LTQ@LTP
300@57.93
ATP
58.07
Var Margin
22 %
Circuit Range
54.52-60.24
Delivery %
59.62 %
Value
5.74 L
ASM/GSM
No
Market Lot
1
Summary
Lyka Labs share price is ₹57.93 as of 3 Jun, 2026. The stock Lyka Labs intraday movement has stayed between ₹57.50 and ₹59.40, while on a 52-week basis,Lyka Labs price 52 week high is ₹128.78 & its 52 week low is ₹44.10.
In terms of trading activity, Lyka Labs has recorded a volume of 9884 shares, The Lyka Labs has a market cap of ₹35690000 CR. The stock’s Average Traded Price (ATP) stands at ₹58.07, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 300 @ ₹57.93.
Lyka Labs operates within a circuit range of ₹54.52 – ₹60.24, with a Value of ₹5.74 L. The Delivery Percentage for the day is 59.62%. Additionally, Lyka Labs currently falls under the No framework, and trades with a market lot size of 1.
Lyka Labs Fundamentals
View MoreP/E Ratio
0
P/B Ratio
2.25
Div. Yield
0
Sector P/E
69.96
Sector P/B
3.01
Sec. Div. Yield
0.55
Lyka Labs Resistance and Support
Pivot 58.29
Resistance
First Resistance
59.58
Second Resistance
61.77
Third Resistance
63.06
Support
First Support
56.1
Second Support
54.81
Third Support
52.62
Lyka Labs Corporate Actions
| Date | Agenda |
|---|---|
| 2026-03-31 | Others |
| 2026-01-29 | Quarterly Results |
| 2025-11-12 | Quarterly Results & Others |
| 2025-09-29 | Others |
| 2025-08-01 | Quarterly Results |
| 2025-05-26 | Audited Results |
| 2025-02-04 | Quarterly Results |
Lyka Labs News
Lyka Labs Ltd - 500259 - Board Meeting Outcome for Outcome Of The Board Meeting Held On 25Th May, 2026
Lyka Labs reported a Q4 FY26 cons. net loss of ₹8.07 crores and recognized a ₹23.01 crore impairment loss in its subsidiary Lyka BDR International Limited due to operational losses. The board approved the financial results and set June 4, 2026, as the record date for share allotment under the amalgamation scheme with Lyka Exports Limited.
May 25 2026 15:38:15
Lyka Labs Ltd - 500259 - Board Meeting Intimation for Approval Of Audited Results
Lyka Labs board to meet on May 25, 2026. The agenda includes considering and approving the audited standalone and consolidated financial results for Q4 FY26.
May 12 2026 16:35:13
Lyka Labs Management
| Name | Position |
|---|---|
| Babulal Jain | Chairman |
| Yogesh Shah | Whole Time Director |
Lyka Labs FAQs
The Buying Price of Lyka Labs share is 57.93 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Lyka Labs stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Lyka Labs, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Lyka Labs shares is 0. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Lyka Labs shares is 2.25. Useful to assess the stock's value relative to its book value.
To assess Lyka Labs’s valuation compare Sector P/E, P/B which are 69.96 & 3.01 with sector averages, along with growth rates and financial metrics.
The Market Cap of Lyka Labs is 206.75 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Lyka Labs share price is 128.78 & 44.10. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Lyka Labs belongs to the Healthcare sector.
